Page last updated: 2024-08-24

rhodamine 123 and Syndrome

rhodamine 123 has been researched along with Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bussel, J; Cunningham-Rundles, S; Gorlick, R; Levy, AS; Mazza, B; Simm, M1
Cavalcanti, GB; de Almeida Dobbin, J; Klumb, CE; Maia, RC; Pinto de Faria, G; Scheiner, MA; Vasconcelos, FC1

Other Studies

2 other study(ies) available for rhodamine 123 and Syndrome

ArticleYear
High P-glycoprotein-mediated export observed in patients with a history of idiopathic thrombocytopenic purpura.
    British journal of haematology, 2002, Volume: 118, Issue:3

    Topics: Adolescent; Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autoimmune Diseases; Cell Culture Techniques; Female; Fluorescent Dyes; Humans; Lymphocytes; Male; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Reverse Transcriptase Polymerase Chain Reaction; Rhodamine 123; Syndrome; Thrombocytopenia

2002
Coexpression of p53 protein and MDR functional phenotype in leukemias: the predominant association in chronic myeloid leukemia.
    Cytometry. Part B, Clinical cytometry, 2004, Volume: 61, Issue:1

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Bone Marrow Cells; Drug Resistance, Multiple; Flow Cytometry; Fluorescent Dyes; Genes, MDR; Humans; K562 Cells; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mutation; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Rhodamine 123; Syndrome; Time Factors; Tumor Suppressor Protein p53

2004